<unk>  is a direct thrombin inhibitor that is FDA approved for the {{{indicationType}}} of thrombosis in heparin-induced thrombocytopenia and prophylaxis in PCI.   Common adverse reactions include dyspnea, hypotension, fever, diarrhea, chest pain, back pain, nausea, vomiting, headache, sepsis, and cardiac arrest.
Argatroban
Otamixaban
Apixaban
Hirudin
Enoxaparin
Bivalirudin
Lusutrombopag
Lepirudin 